- Home
- AVBH vs NBTX Comparison
AVBH vs NBTX Comparison
Compare AVBH & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBH
- NBTX
- Stock Information
- Founded
- AVBH 2003
- NBTX 2003
- Country
- AVBH United States
- NBTX France
- Employees
- AVBH N/A
- NBTX N/A
- Industry
- AVBH
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- AVBH
- NBTX Health Care
- Exchange
- AVBH Nasdaq
- NBTX Nasdaq
- Market Cap
- AVBH 189.6M
- NBTX 211.9M
- IPO Year
- AVBH N/A
- NBTX 2020
- Fundamental
- Price
- AVBH $24.20
- NBTX $7.91
- Analyst Decision
- AVBH Strong Buy
- NBTX Strong Buy
- Analyst Count
- AVBH 2
- NBTX 1
- Target Price
- AVBH $25.50
- NBTX $8.00
- AVG Volume (30 Days)
- AVBH 60.6K
- NBTX 10.6K
- Earning Date
- AVBH 10-20-2025
- NBTX 09-17-2025
- Dividend Yield
- AVBH N/A
- NBTX N/A
- EPS Growth
- AVBH 33.46
- NBTX N/A
- EPS
- AVBH 2.78
- NBTX N/A
- Revenue
- AVBH $77,810,000.00
- NBTX N/A
- Revenue This Year
- AVBH $15.40
- NBTX N/A
- Revenue Next Year
- AVBH $16.94
- NBTX $74.67
- P/E Ratio
- AVBH $8.70
- NBTX N/A
- Revenue Growth
- AVBH 14.57
- NBTX N/A
- 52 Week Low
- AVBH $18.85
- NBTX $2.76
- 52 Week High
- AVBH $26.59
- NBTX $8.47
- Technical
- Relative Strength Index (RSI)
- AVBH N/A
- NBTX 73.17
- Support Level
- AVBH N/A
- NBTX $6.97
- Resistance Level
- AVBH N/A
- NBTX $8.47
- Average True Range (ATR)
- AVBH 0.00
- NBTX 0.40
- MACD
- AVBH 0.00
- NBTX 0.07
- Stochastic Oscillator
- AVBH 0.00
- NBTX 76.47
About AVBH Avidbank Holdings Inc. Common stock
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.